Inhibiting post-translational methylation to prevent GVHD.
作者信息
Mavers Melissa
机构信息
Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
出版信息
Mol Ther. 2023 Nov 1;31(11):3115-3116. doi: 10.1016/j.ymthe.2023.10.009. Epub 2023 Oct 20.
Abstract
摘要
相似文献
1
Inhibiting post-translational methylation to prevent GVHD.抑制翻译后甲基化以预防移植物抗宿主病。
Mol Ther. 2023 Nov 1;31(11):3115-3116. doi: 10.1016/j.ymthe.2023.10.009. Epub 2023 Oct 20.
2
Advances in the prevention of graft-versus-host disease after hematopoietic cell transplantation.造血细胞移植后移植物抗宿主病预防的进展
Transplantation. 2004 May 15;77(9 Suppl):S79-83. doi: 10.1097/01.tp.0000126932.51759.85.
3
Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease.移植后大剂量环磷酰胺用于预防移植物抗宿主病。
Biol Blood Marrow Transplant. 2015 Apr;21(4):604-11. doi: 10.1016/j.bbmt.2014.08.014. Epub 2014 Aug 23.
4
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.一项双臂2期临床试验的结果，该试验使用移植后环磷酰胺预防单倍体相合供者和错配无关供者造血干细胞移植中的移植物抗宿主病。
Cancer. 2016 Nov 15;122(21):3316-3326. doi: 10.1002/cncr.30180. Epub 2016 Jul 12.
5
Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.移植物抗宿主病：造血干细胞移植的一种复杂的长期副作用。
Oncology (Williston Park). 2008 Oct;22(11 Suppl Nurse Ed):31-45.
6
A new standard treatment for prevention of GvHD after HCT?
Lancet Haematol. 2019 Mar;6(3):e113-e114. doi: 10.1016/S2352-3026(19)30015-8.
7
Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases.移植物抗宿主病对非恶性疾病异基因造血干细胞移植临床结局的影响。
Int J Hematol. 2020 Jun;111(6):869-876. doi: 10.1007/s12185-020-02839-4. Epub 2020 Feb 12.
8
Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.中药治疗异基因造血干细胞移植后移植物抗宿主病。
Chin J Integr Med. 2020 May;26(5):324-329. doi: 10.1007/s11655-020-3252-y. Epub 2020 Apr 29.
9
Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft‑vs.‑host disease in mice.人腭扁桃体间充质干细胞条件培养基减轻小鼠急性移植物抗宿主病。
Mol Med Rep. 2019 Jan;19(1):609-616. doi: 10.3892/mmr.2018.9659. Epub 2018 Nov 13.
10
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation.一项关于移植后环磷酰胺联合他克莫司预防 HLA 匹配的亲缘/非亲缘异基因造血干细胞移植后移植物抗宿主病的 II 期研究。
Int J Hematol. 2022 Jan;115(1):77-86. doi: 10.1007/s12185-021-03228-1. Epub 2021 Sep 29.
本文引用的文献
1
Targeting PRMT1 prevents acute and chronic graft-versus-host disease.靶向 PRMT1 可预防急性和慢性移植物抗宿主病。
Mol Ther. 2023 Nov 1;31(11):3259-3276. doi: 10.1016/j.ymthe.2023.09.011. Epub 2023 Sep 20.
2
The Influence of Arginine Methylation in Immunity and Inflammation.精氨酸甲基化在免疫和炎症中的影响。
J Inflamm Res. 2022 May 13;15:2939-2958. doi: 10.2147/JIR.S364190. eCollection 2022.
3
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.贝罗莫苏德利治疗 2 线及以上治疗后的慢性移植物抗宿主病：ROCKstar 研究。
Blood. 2021 Dec 2;138(22):2278-2289. doi: 10.1182/blood.2021012021.
4
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.芦可替尼治疗糖皮质激素难治性慢性移植物抗宿主病。
N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122.
5
Protein arginine methylation: from enigmatic functions to therapeutic targeting.蛋白质精氨酸甲基化：从神秘功能到治疗靶点。
Nat Rev Drug Discov. 2021 Jul;20(7):509-530. doi: 10.1038/s41573-021-00159-8. Epub 2021 Mar 19.
6
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.阿巴西普阻断共刺激用于预防急性移植物抗宿主病的 II 期临床试验。
J Clin Oncol. 2021 Jun 10;39(17):1865-1877. doi: 10.1200/JCO.20.01086. Epub 2021 Jan 15.
7
Metabolic Reprogramming Induces Germinal Center B Cell Differentiation through Bcl6 Locus Remodeling.代谢重编程通过 Bcl6 基因座重塑诱导生发中心 B 细胞分化。
Cell Rep. 2020 Nov 3;33(5):108333. doi: 10.1016/j.celrep.2020.108333.
8
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.PRMT5 调节 T 细胞干扰素反应，是急性移植物抗宿主病的靶点。
JCI Insight. 2020 Apr 23;5(8):131099. doi: 10.1172/jci.insight.131099.
9
Modern approaches to HLA-haploidentical blood or marrow transplantation.HLA单倍型相合血液或骨髓移植的现代方法。
Nat Rev Clin Oncol. 2016 Jan;13(1):10-24. doi: 10.1038/nrclinonc.2015.128. Epub 2015 Aug 25.
10
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1.对氨基苯磺酰胺和氨苯砜的酰基衍生物作为精氨酸甲基转移酶 hPRMT1 的新型抑制剂。
Bioorg Med Chem. 2011 Jun 15;19(12):3717-31. doi: 10.1016/j.bmc.2011.02.032. Epub 2011 Feb 27.
Zotero 插件